Antares Pharma, Inc.
(NASDAQ : ATRS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
MDTMedtronic PLC
0.91%96.900.6%$494.54m
ABTAbbott Laboratories
1.10%68.420.8%$296.17m
ISRGIntuitive Surgical, Inc.
1.06%564.552.4%$255.20m
TMOThermo Fisher Scientific Inc.
0.18%238.891.0%$244.79m
ALGNAlign Technology, Inc.
1.85%385.376.3%$230.22m
BAXBaxter International Inc.
0.45%77.391.7%$209.21m
BSXBoston Scientific Corporation
0.32%37.391.1%$205.90m
BDXBecton, Dickinson and Company
0.92%259.591.1%$205.54m
SYKStryker Corporation
1.24%171.991.3%$171.42m
ABMDABIOMED, Inc.
1.45%374.233.3%$168.07m
EWEdwards Lifesciences Corporation
-0.01%146.281.2%$133.33m
TNDMTandem Diabetes Care, Inc.
-8.89%36.614.1%$129.84m
DXCMDexCom, Inc.
1.00%139.318.5%$128.14m
ZBHZimmer Biomet Holdings, Inc.
0.46%130.141.7%$127.25m
XRAYDENTSPLY International Inc.
0.21%38.183.0%$104.20m

Company Profile

Antares Pharma, Inc. is a pharmaceutical company. The company focuses on the development and commercialization of self-administered parenteral pharmaceutical products and technologies. Its activities include the development of injection devices and injection based pharmaceutical products as well as transdermal gel products. The company was founded in February 1979 and is headquartered in Ewing, NJ.